Search clinical trials for: Coronary Restenosis

Total 9866 results

The University of Hong Kong

Completed

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Coronary Restenosis

China
Biosensors Europe SA

Completed

BioFreedom FIM Clinical Trial.

Treatment Of Stenotic Lesions In Native Coronary Arteries.

Germany
Xuzhou Central Hospital

Unknown

The Comparative Study of OCT，Gemstone CT and 320-detector Row Spiral CT for Evaluating Restenosis of Coronary Artery Stent

Coronary Heart Disease

China
Medstar Health Research Institute

Unknown

Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation

In-stent Coronary Artery Restenosis

United States
University of Ulm
B. Braun Melsungen AG; OrbusNeich

Completed

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries

Coronary Artery Disease

Germany
Kumamoto University

Completed

Impaired Peripheral Endothelial Function and In-stent Restenosis

Coronary Artery Disease

Japan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
S.M. Misericordia Hospital

Completed

Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions (DESERT)

Stable Coronary Artery Disease | Silent Myocardial Ischemia | In-stent(BMS)Restenosis | De-novo, Atherosclerotic, Coronary Lesions

Italy
Abbott Medical Devices

Terminated

ABSORB PHYSIOLOGY Clinical Investigation

Coronary Artery Disease

Netherlands, Australia, Singapore, China
Biotronik AG

Completed

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis (PEPPER)

In-stent Coronary Artery Restenosis

Germany
University of Roma La Sapienza

Unknown

Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation (TOP RACER)

Coronary Artery Disease
Prof. Stephen Lee

Completed

OCT Evaluation of Healing of COMBO Stent (EGO-COMBO)

Coronary Thrombosis | Coronary Restenosis

Hong Kong
Universita di Verona
Regione Piemonte

Completed

Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

Coronary Artery Disease | Atherosclerosis | Ischemic Heart Disease

Italy
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Abbott Medical Devices

Completed

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

EXCEL Clinical Trial (Universal Registry) (EXCEL)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Left Main Coronary Artery Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1) (XVU-Phase 1)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Coronary Artery Disease

United States
North Texas Veterans Healthcare System

Completed

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions (SOS-Xience V)

Coronary Artery Bypass | Atherosclerosis

United States
Abbott Medical Devices

Completed

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period (XERES)

Coronary Restenosis

France
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
Shanghai Zhongshan Hospital

Unknown

Genetics Study of In-stent Restenosis (ISR)

Coronary Artery Disease

China
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Focal In-stent Restenosis After Drug-Eluting Stent (FOCUS)

In Stent Restenosis

Korea, Republic of
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
B.Braun Surgical SA
Hospital Universitario Infanta Cristina de Badajoz

Unknown

Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions (BABILON)

Coronary Artery Disease

Spain
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
North Texas Veterans Healthcare System
US Department of Veterans Affairs; University of Arkansas; Michael E. DeBakey... and other collaborators

Completed

The SOS (Stenting Of Saphenous Vein Grafts) Trial

Arteriosclerosis | Coronary Artery Bypass

United States, Greece
Medtronic Vascular

Completed

The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions (ENDEAVOR IV)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France (Far XIENCE V®)

Coronary Artery Disease

France
Celgene Corporation

Completed

Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis (SNAPIST-III)

Coronary Restenosis
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Cook Group Incorporated

Completed

The ELUTES Clinical Trial (ELUTES I)

Coronary Artery Disease

United States
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
University of Campania "Luigi Vanvitelli"

Completed

Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis

Restenosis | Tight Glycemic Control

Italy
Assistance Publique - Hôpitaux de Paris
Volcano Corporation

Completed

FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries

Coronary Artery Insufficiency

France
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Azienda Ospedaliero Universitaria Maggiore della...

Completed

Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis

Myocardial Infarction | Restenosis

Italy
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Cordis Corporation
Conor Medsystems

Completed

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Coronary Disease

United States
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Medtronic Vascular

Completed

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial (ENDEAVOR III)

Coronary Artery Disease

Search clinical trials for: Coronary Restenosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations